Viewing Study NCT00208013



Ignite Creation Date: 2024-05-05 @ 11:59 AM
Last Modification Date: 2024-10-26 @ 9:18 AM
Study NCT ID: NCT00208013
Status: COMPLETED
Last Update Posted: 2010-11-29
First Post: 2005-09-13

Brief Title: The Survey About Resting Metabolic Rate and Its Related Factors in Terminal Patients
Sponsor: China Medical University Hospital
Organization: China Medical University Hospital

Study Overview

Official Title: The Survey About Resting Metabolic Rate and Its Related Factors in Terminal Patients
Status: COMPLETED
Status Verified Date: 2005-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Cachectic patients often lose their appetite lose weight and are prone to weakness and even death in advanced illness Nutrition therapy is important and of concern to the investigators in cancer patients More than 80 of terminal cancer or advanced illness patients get cachexia Cachexia is a complex multifactorial syndrome that results from a reduction in food intake a variety of metabolic abnormalities including hypermetabolism or more often a combination of the two Cachexia will progress with disease progression Cachexia or weight loss is often the major cause of death or poor quality of life

The change of resting energy expenditure REE is different in various tumor types Most experts agree that the REE will increase in cancer cachexia syndrome The more weight loss the more cachexia will occur

Overnutrition is not beneficial in terminal patients according to the Chiu and Easson studies As the investigators know few studies focus on REE in terminal patients In this study samples are from a hospice palliative ward or from hospice home care patients in a medical center in mid-Taiwan About 100 patients will be recruited The investigators will analyze the relationship between REE and its related factors After finishing the study they will provide more evidence for treating cachexia in terminal patients
Detailed Description: According to data from the Taiwanese government cancer mortality has been the leading cause of death in Taiwan since 1982 The trend is increasing day by day As the people are aging in Taiwan the incidence of cancer will increase and it will be more important than before

Cachectic patients often lose their appetite lose weight and are prone to weakness and even death in advanced illness Nutrition therapy is important and of concern to the investigators in cancer patients More than 80 of terminal cancer or advanced illness patients get cachexia Cachexia is a complex multifactorial syndrome that results from a reduction in food intake a variety of metabolic abnormalities including hypermetabolism or more often a combination of the two Cachexia will progress with disease progression Cachexia or weight loss is often the major cause of death or poor quality of life

The change of resting energy expenditure REE is different in various tumor types Most experts agree that the REE will increase in cancer cachexia syndrome The more weight loss the more cachexia will occur

Overnutrition is not beneficial in terminal patients according to the Chiu and Easson studies As the investigators know few studies focus on REE in terminal patients In this study samples are from a hospice palliative ward or from hospice home care patients in a medical center in mid-Taiwan About 100 patients will be recruited The investigators will analyze the relationship between REE and its related factors After finishing the study they will provide more evidence for treating cachexia in terminal patients

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None